PMS-DEFERASIROX (TYPE J)

Identification of Pms-Deferasirox (Type J)

No description

Google image searchProduct monograph

Active ingredient

deferasirox, 180 MG

DIN: 02528304

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: PHARMASCIENCE INC

Date: 30-SEP-2022

ATC:

• V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
• V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
• V03AC — Iron chelating agents (ATC, ATC/DDD)
• V03AC03 — DEFERASIROX (ATC/DDD)

Reference brand drug: Exjade

External Links for Pms-Deferasirox (Type J)

Search on Google

• Pms-Deferasirox (Type J) side effects
• Pms-Deferasirox (Type J) dosage
• deferasirox side effects
• deferasirox dosage

Pharmascience Inc

Go to Pharmascience website to see drug product details. Sometimes you can find pms-deferasirox (type j) photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.